Profen and Trelegy ellipta drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Profen (ibuprofen) and Trelegy ellipta (fluticasone furoate; umeclidinium bromide; vilanterol trifenatate). Common drug interactions include infusion site swelling among females and dyspnoea among males.
The phase IV clinical study analyzes what interactions people have when they take Profen and Trelegy ellipta. It is created by eHealthMe based on reports of 364 people who take the same drugs from the FDA, and is updated regularly.
What is Profen?
Profen has active ingredients of ibuprofen. It is often used in pain. eHealthMe is studying from 245,311 Profen users. Check the latest studies of Profen.
What is Trelegy ellipta?
Trelegy ellipta has active ingredients of fluticasone furoate; umeclidinium bromide; vilanterol trifenatate. eHealthMe is studying from 28,101 Trelegy ellipta users. Check the latest studies of Trelegy ellipta.
364 people who take Profen and Trelegy ellipta together, and have interactions are studied.
What are the common drug interactions of Profen and Trelegy ellipta, by gender? *
What are the common drug interactions of Profen and Trelegy ellipta, by age (0-1 to 60+)? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Profen and Trelegy ellipta?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Profen (245,311 reports)
- Trelegy ellipta (28,101 reports)
Browse all drug interactions of Profen and Trelegy ellipta:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Profen:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Trelegy ellipta:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Profen and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Trelegy ellipta and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Moslim MA, Sodeman TC, Nawras AT, "A Case of Suggested Ibuprofen-Induced Acute Pancreatitis", American journal of therapeutics, 2016 Nov .
- Moslim MA, Sodeman TC, Nawras AT, "A Case of Suggested Ibuprofen-Induced Acute Pancreatitis", American journal of therapeutics, 2016 Nov .
How the study uses the data?
The study uses data from the FDA. It is based on ibuprofen and fluticasone furoate; umeclidinium bromide; vilanterol trifenatate (the active ingredients of Profen and Trelegy ellipta, respectively), and Profen and Trelegy ellipta (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Chronic Myeloid Leukaemia and Vasodilatation - 5 seconds ago
- Ondansetron vs. Lorazepam, side effect and effectiveness comparison - 7 seconds ago
- Could Zofran cause Pulmonary Arterial Pressure Increased? - 20 seconds ago
- Zofran Odt vs. Lorazepam, side effect and effectiveness comparison - 21 seconds ago
- Drug interactions of Macrodantin and Cozaar - 27 seconds ago
- Risperdal and Amoxicillin drug interactions for boys aged 10-19 - 45 seconds ago
- Diovan and Taste - Impaired for Men aged 50-59 - 47 seconds ago
- Diovan and Metallic Taste for Men aged 50-59 - 47 seconds ago
- Diovan and Dysgeusia for Men aged 50-59 - 48 seconds ago
- Diovan and Loss Of Taste for Men aged 50-59 - 48 seconds ago